Dermatology Activities
Biosimilars: A Managed Care Update of Real-World Evidence and Cost-Savings Data When Treating Inflammatory Conditions
0290-0000-20-298-H01-P
This activity will identify the patient populations with rheumatic and inflammatory disease and consider the biologic costs associated with pharmacologic treatment.
1.00
Addressing the Needs of Adolescent Patients With Moderate to Severe Atopic Dermatitis
0290-0000-20-071-H01-P
This activity will explain atopic dermatitis pathophysiology, including the role of interleukins in type 2 inflammation and disease pathology.
1.00
Reviewing Interleukin 17— and Interleukin 23—targeting Therapies and Best Practices in Psoriatic Disease Management Feat. Clinical Practice Video Vignettes
0290-0000-20-043-H01-P
This activity includes patient counseling videos that highlight the vital roles of specialty pharmacists in assisting patients with PsO and PsA via clinical interventions, educating patients about administration, and monitoring patient response and adherence to selected therapy.
2.00